NCT06462742View on ClinicalTrials.gov

Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2009

Primary Completion Date

June 1, 2029

Study Completion Date

June 1, 2029

Conditions

Overall SurvivalDisease-free Survival

Interventions

PROCEDURE

Microwave ablation (MWA) versus Liver Resection (LR)

"Microwave ablation (MWA) is one of the newer modality of thermal ablation and has proven its safety and efficacy in the management of the tumors amenable for ablation for primary and metastatic diseases.~Liver resection is a surgery to remove part of the liver to eradicate tumors."

Trial Locations (1)

100853

RECRUITING

Chinese PLA General Hospital, Beijing

All Listed Sponsors

lead

Chinese PLA General Hospital

OTHER

NCT06462742 - Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma | Biotech Hunter | Biotech Hunter